• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微小RNA介导的与阿尔茨海默病相关的线粒体功能和基因调控

miRNA mediated mitochondrial function and gene regulation associated with Alzheimer's disease.

作者信息

Subasinghe Kumudu, Barber Robert, Phillips Nicole

机构信息

Department of Microbiology, Immunology, and Genetics, University of North Texas Health Science Center, Fort Worth, TX, United States.

Department of Family Health, University of North Texas Health Science Center, Fort Worth, TX, United States.

出版信息

Front Aging. 2025 May 13;6:1582812. doi: 10.3389/fragi.2025.1582812. eCollection 2025.

DOI:10.3389/fragi.2025.1582812
PMID:40433169
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12106540/
Abstract

MicroRNAs (miRNAs) are small non-coding RNA molecules that are known to regulate gene expression in their target locations thereby contributing to epigenetic mechanisms associated with disease pathologies. Dysregulation of miRNA activity has been implicated in the pathology of Alzheimer's disease (AD), offering insights into potential biomarkers for early diagnosis and therapeutic targets. Mitochondrial dysfunction and its associated effects (such as oxidative stress) can be seen in early-onset AD. This review critically examines recent findings on mitochondrial-associated miRNAs-including miR-34a, miR-140, miR-455-3p, and miR-1273g-3p-highlighting their roles in mitochondrial bioenergetics, oxidative stress, and synaptic function. We discuss the therapeutic potential of targeting specific miRNAs to restore mitochondrial health and explore their utility as early biomarkers for AD diagnosis. A better understanding of miRNA-mediated mitochondrial regulation may open new avenues for early intervention in AD.

摘要

微小RNA(miRNA)是一类小的非编码RNA分子,已知其可在靶位点调节基因表达,从而参与与疾病病理相关的表观遗传机制。miRNA活性失调与阿尔茨海默病(AD)的病理过程有关,这为早期诊断的潜在生物标志物和治疗靶点提供了线索。线粒体功能障碍及其相关影响(如氧化应激)在早发性AD中可见。本综述批判性地审视了关于线粒体相关miRNA的最新研究结果,包括miR-34a、miR-140、miR-455-3p和miR-1273g-3p,强调了它们在线粒体生物能量学、氧化应激和突触功能中的作用。我们讨论了靶向特定miRNA以恢复线粒体健康的治疗潜力,并探讨了它们作为AD诊断早期生物标志物的值用性。更好地理解miRNA介导的线粒体调节可能为AD的早期干预开辟新途径。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2c6/12106540/f54655801967/fragi-06-1582812-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2c6/12106540/f54655801967/fragi-06-1582812-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2c6/12106540/f54655801967/fragi-06-1582812-g001.jpg

相似文献

1
miRNA mediated mitochondrial function and gene regulation associated with Alzheimer's disease.微小RNA介导的与阿尔茨海默病相关的线粒体功能和基因调控
Front Aging. 2025 May 13;6:1582812. doi: 10.3389/fragi.2025.1582812. eCollection 2025.
2
Enhanced Expression of microRNA-1273g-3p Contributes to Alzheimer's Disease Pathogenesis by Regulating the Expression of Mitochondrial Genes.微小 RNA-1273g-3p 的表达增强通过调节线粒体基因的表达促进阿尔茨海默病的发病机制。
Cells. 2021 Oct 9;10(10):2697. doi: 10.3390/cells10102697.
3
Plasma miR-34a-5p and miR-545-3p as Early Biomarkers of Alzheimer's Disease: Potential and Limitations.血浆 miR-34a-5p 和 miR-545-3p 作为阿尔茨海默病的早期生物标志物:潜力和局限性。
Mol Neurobiol. 2017 Sep;54(7):5550-5562. doi: 10.1007/s12035-016-0088-8. Epub 2016 Sep 8.
4
MicroRNA-455-3P as a peripheral biomarker and therapeutic target for mild cognitive impairment and Alzheimer's disease.miRNA-455-3P 作为轻度认知障碍和阿尔茨海默病的外周生物标志物和治疗靶点。
Ageing Res Rev. 2024 Sep;100:102459. doi: 10.1016/j.arr.2024.102459. Epub 2024 Aug 15.
5
MicroRNA-Seq Data Analysis Pipeline to Identify Blood Biomarkers for Alzheimer's Disease from Public Data.用于从公共数据中识别阿尔茨海默病血液生物标志物的MicroRNA测序数据分析流程
Biomark Insights. 2015 Apr 15;10:21-31. doi: 10.4137/BMI.S25132. eCollection 2015.
6
RNA and Oxidative Stress in Alzheimer's Disease: Focus on microRNAs.阿尔茨海默病中的 RNA 和氧化应激:聚焦 microRNAs。
Oxid Med Cell Longev. 2020 Nov 30;2020:2638130. doi: 10.1155/2020/2638130. eCollection 2020.
7
The role of microRNAs in understanding sex-based differences in Alzheimer's disease.microRNAs 在理解阿尔茨海默病性别差异中的作用。
Biol Sex Differ. 2024 Jan 31;15(1):13. doi: 10.1186/s13293-024-00588-1.
8
Cerebrovascular miRNAs Track Early Development of Alzheimer's Disease and Target Molecular Markers of Angiogenesis and Blood Flow Regulation.脑血管 miRNAs 追踪阿尔茨海默病的早期发展,并靶向血管生成和血流调节的分子标志物。
J Alzheimers Dis. 2024;99(s2):S187-S234. doi: 10.3233/JAD-230300.
9
MicroRNAs as Potential Orchestrators of Alzheimer's Disease-Related Pathologies: Insights on Current Status and Future Possibilities.微小RNA作为阿尔茨海默病相关病理的潜在调控者:对现状与未来可能性的见解
Front Aging Neurosci. 2021 Oct 12;13:743573. doi: 10.3389/fnagi.2021.743573. eCollection 2021.
10
microRNA-34a (miRNA-34a) Mediated Down-Regulation of the Post-synaptic Cytoskeletal Element SHANK3 in Sporadic Alzheimer's Disease (AD).微小RNA-34a(miRNA-34a)介导散发性阿尔茨海默病(AD)中突触后细胞骨架元件SHANK3的下调。
Front Neurol. 2019 Feb 6;10:28. doi: 10.3389/fneur.2019.00028. eCollection 2019.

本文引用的文献

1
Epigenetics-targeted drugs: current paradigms and future challenges.表观遗传学靶向药物:当前范例与未来挑战。
Signal Transduct Target Ther. 2024 Nov 26;9(1):332. doi: 10.1038/s41392-024-02039-0.
2
MicroRNAs: pioneering regulators in Alzheimer's disease pathogenesis, diagnosis, and therapy.微小 RNA:阿尔茨海默病发病机制、诊断和治疗的先驱调控因子。
Transl Psychiatry. 2024 Sep 10;14(1):367. doi: 10.1038/s41398-024-03075-8.
3
Recent advances in Alzheimer's disease: Mechanisms, clinical trials and new drug development strategies.
阿尔茨海默病的最新进展:机制、临床试验和新药研发策略。
Signal Transduct Target Ther. 2024 Aug 23;9(1):211. doi: 10.1038/s41392-024-01911-3.
4
MicroRNA-455-3P as a peripheral biomarker and therapeutic target for mild cognitive impairment and Alzheimer's disease.miRNA-455-3P 作为轻度认知障碍和阿尔茨海默病的外周生物标志物和治疗靶点。
Ageing Res Rev. 2024 Sep;100:102459. doi: 10.1016/j.arr.2024.102459. Epub 2024 Aug 15.
5
Role of microRNA-34a in blood-brain barrier permeability and mitochondrial function in ischemic stroke.微小RNA-34a在缺血性脑卒中血脑屏障通透性及线粒体功能中的作用
Front Cell Neurosci. 2023 Oct 19;17:1278334. doi: 10.3389/fncel.2023.1278334. eCollection 2023.
6
A first-in-class fully modified version of miR-34a with outstanding stability, activity, and anti-tumor efficacy.一种具有卓越稳定性、活性和抗肿瘤疗效的 miR-34a 全修饰的同类首创药物。
Oncogene. 2023 Sep;42(40):2985-2999. doi: 10.1038/s41388-023-02801-8. Epub 2023 Sep 5.
7
Mitochondria Localized microRNAs: An Unexplored miRNA Niche in Alzheimer's Disease and Aging.线粒体定位 microRNAs:阿尔茨海默病和衰老中未被探索的 miRNA 生态位。
Cells. 2023 Feb 25;12(5):742. doi: 10.3390/cells12050742.
8
Identification of Timm13 protein translocase of the mitochondrial inner membrane as a potential mediator of liver fibrosis based on bioinformatics and experimental verification.基于生物信息学和实验验证鉴定 Timm13 蛋白作为潜在的肝纤维化介导线粒体内膜转位酶。
J Transl Med. 2023 Mar 10;21(1):188. doi: 10.1186/s12967-023-04037-2.
9
Targeting Novel microRNAs in Developing Novel Alzheimer's Disease Treatments.靶向新型微小RNA开发新型阿尔茨海默病治疗方法
Neurochem Res. 2023 Jan;48(1):26-38. doi: 10.1007/s11064-022-03734-6. Epub 2022 Sep 1.
10
SPOROS: A pipeline to analyze DISE/6mer seed toxicity.SPOROS:用于分析 DISE/6mer 种子毒性的管道。
PLoS Comput Biol. 2022 Mar 31;18(3):e1010022. doi: 10.1371/journal.pcbi.1010022. eCollection 2022 Mar.